right-icon

Back to blog

Research Highlights Addition of anti-inflammatory lipids may alleviate immune activation from pDNA-LNPs - Echelon Biosciences

Addition of anti-inflammatory lipids blocks toxicity from pDNA-LNPs

Interest in ionizable lipids and lipid nanoparticles (LNPs) continues to accelerate, and as the field grows novel cargos and lipid...

3 minute read
By Cameron Day
January 17

Interest in ionizable lipids and lipid nanoparticles (LNPs) continues to accelerate, and as the field grows novel cargos and lipid formulations are being explored to address common therapeutic barriers. mRNA-LNPs have proven successful, but the inherent disadvantages of mRNA such as short half-life and immunogenicity may prohibit its use in some therapeutic cases. To combat the issue of half-life, new types of RNA cargo are being developed such as self-amplifying RNA (saRNA) and circular RNA (circRNA). A less well-studied alternative cargo for LNPs is plasmid DNA.

Plasmid DNA (pDNA) has distinct advantages over RNAs in terms of stability, long term expression, and the ability to encode promoters that enable cell-specific expression. The chief drawback to using pDNA in vivo is that it is well known to activate the cGAS-STING pathway. cGAS is a cytosolic DNA sensor that activates STING when bound to DNA and triggers an extensive cellular inflammatory response. Therefore, a secondary means of inhibiting inflammation must be included if pDNA is to be utilized in a LNP therapy. In the current study, Patel et al. provide evidence that inclusion of anti-inflammatory lipids in pDNA-LNP formulations blocks STING-mediated inflammation.

Schematic of loading NOA to pDNA-LNPs as it relates to cellular inflammation and toxicity - Echelon Biosciences

First, the authors establish that pDNA-LNPs activate cGAS-STING at similar levels to common transfection reagents in both cell culture and an animal model. These effects were also dose dependent. They next hypothesized that addition of specific unsaturated fatty acids such as Linoleic acid (LA), and Oleic acid (OA) could blunt the toxic effects of pDNA. These lipids have been shown to inhibit certain pro-inflammatory genes and activate antioxidant signaling pathways. Initial in vitro screens showed that nitrated versions of LA and OA (NLA, NOA - Echelon L-0112) dramatically reduced immune activation when added to pDNA-LNP formulations. Subsequent experiments provide evidence that pDNA toxicity is also abrogated in vivo when NOA is present in the LNP, and that reporter gene expression is sustained for several weeks.

Their current data suggest that NOA addition to LNPs could allow for pDNA to be used as a potential therapeutic cargo similar to siRNA and mRNA. Whether this strategy is generalizable to other types of nucleic acid LNPs was not explored, but it raises the possibility of anti-inflammatory components in LNPs in addition to or in place of nucleoside modified cargos.

Echelon's Ionizable lipids (D-Lin-MC3-DMA, ALC-0315, and SM-102), ALC-0159, and nitro-oleic acid (NOA) were used in this work (Cat# N-1282, N-1102, N-1020, L-0112, respectively).

Read the full article here:

Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids

Nature Biotechnology (2025)

0.2

/ 0.3

Related Articles

Stay informed with our informative blog posts.

Research Highlights
Addition of anti-inflammatory lipids may alleviate immune activation from pDNA-LNPs - Echelon Biosciences

Addition of anti-inflammatory lipids blocks toxicity from pDNA-LNPs

Interest in ionizable lipids and lipid nanoparticles (LNPs) continues to accelerate, and as the field grows novel cargos and lipid

3 minute read
By Cameron Day
January 17

Research Highlights
Subpopulations of macrophages can promote tumor progression due to HA degradation and remodeling of the ECM - Echelon Biosciences

Certain macrophages degrade HA and drive tumor progression

The relationship between cancer and the immune system is complex. There is intense interest in harnessing immune cells to attack t

2 minute read
By Cameron Day
December 26

Research Highlights
Deep learning networks identify novel ionizable lipids - Echelon Biosciences

Deep learning network identifies novel, functional ionizable lipids

There has been increasing interest over the last decade in harnessing RNA for novel therapuetic modalities. With the approval of t

3 minute read
By Cameron Day
November 22

Research Highlights
hPAC channels are regulated by PI(4,5)P2 to enhance cell survival

PI(4,5)P2 regulates chloride channels during acidosis

Acidic pH is required in some intracellular organelles, but in the extracellular environment it can be highly damaging to cells. E

2 minute read
By Cameron Day
November 1

Research Highlights
Echelon Bioscience - lipid-dependent activation of STING

Lipid-dependent activation of the STING pathway

The cGAS/STING pathway is a critical part of the innate immune system that detects cytosolic DNA and promotes inflammatory respons

2 minute read
By Cameron Day
March 22

Research Highlights
Dissecting microglia to identify new targets in Alzheimer's disease (INPP5D) - Echelon Biosciences

Lipid phosphatase INPP5D emerges as key regulator of inflammasome in microglia

Alzheimer’s disease (AD) has long been characterized by the presence of plaques in neuronal tissue composed primarily of amyloid

3 minute read
By Cameron Day
January 9

0.3

/ 0.3

Get in Touch

If you have any questions or would like to learn more about our services, feel free to reach out to us. We’re here to help!

Contact Echelon
Biosciences
Basket

Your Echelon Basket is empty.